OsI_009113 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
OsI_009113 antibody; Uncharacterized protein OsI_009113 antibody; Unknown protein AN04 from 2D-PAGE of anther antibody
Target Names
OsI_009113
Uniprot No.

Q&A

What is OsI_009113 Antibody and what is its target protein?

OsI_009113 Antibody is a polyclonal antibody specifically designed to target the OsI_009113 protein in Oryza sativa subsp. indica (Rice). The target protein has UniProt accession number A2XAM0 and represents an important research tool for studying rice protein expression and function. The antibody was generated using recombinant Oryza sativa subsp. indica OsI_009113 protein as the immunogen, allowing for specific detection of this target in appropriate experimental systems .

As a polyclonal preparation, this antibody contains a heterogeneous mixture of immunoglobulins that recognize multiple epitopes on the OsI_009113 target protein, potentially providing robust signal detection in various applications. The polyclonal nature can be particularly valuable when studying proteins with complex conformational states or when signal amplification is desired.

What are the recommended storage conditions for OsI_009113 Antibody?

Proper storage of OsI_009113 Antibody is critical for maintaining its activity and specificity. Upon receipt, the antibody should be stored at -20°C or -80°C for long-term stability . Repeated freeze-thaw cycles should be strictly avoided as they can lead to protein denaturation, aggregation, and significant loss of antibody activity. For researchers planning multiple experiments over time, it is advisable to prepare working aliquots upon receipt to minimize freeze-thaw cycles.

The antibody is supplied in a protective storage buffer consisting of:

  • 50% Glycerol

  • 0.01M PBS (pH 7.4)

  • 0.03% Proclin 300 as a preservative

This formulation helps maintain stability during storage periods. When handling the antibody, temperature transitions should be gradual, and exposure to light should be minimized.

How should researchers validate the specificity of OsI_009113 Antibody before experimental use?

Validation of antibody specificity is a critical step before using OsI_009113 Antibody in experimental protocols. I recommend a multi-step validation approach:

  • Positive and negative control tissues: Test the antibody on tissues known to express (rice tissues) and not express (non-rice plant tissues) the target protein.

  • Western blot validation: Run a western blot with rice protein lysates to confirm a single band of appropriate molecular weight. Additionally, pre-absorption of the antibody with the immunizing peptide should eliminate specific binding.

  • Knockout/knockdown validation: If available, use CRISPR or RNAi-generated OsI_009113 knockout/knockdown samples as negative controls.

  • Orthogonal method comparison: Compare results with alternative detection methods such as mass spectrometry or RNA expression analysis.

  • Cross-reactivity testing: Test potential cross-reactivity with closely related rice proteins by heterologous expression systems.

This comprehensive validation approach ensures that experimental results accurately reflect OsI_009113 expression rather than non-specific binding or artifacts.

What are the optimal protocols for using OsI_009113 Antibody in Western Blot applications?

When utilizing OsI_009113 Antibody for Western Blot applications, the following optimized protocol is recommended based on its specifications:

Sample preparation:

  • Extract proteins from rice tissues using a buffer containing protease inhibitors

  • Determine protein concentration (Bradford or BCA assay)

  • Prepare samples (20-50 μg total protein) in Laemmli buffer with reducing agent

  • Heat samples at 95°C for 5 minutes

Gel electrophoresis and transfer:

  • Separate proteins on 10-12% SDS-PAGE

  • Transfer to PVDF membrane (0.45 μm) at 100V for 60-90 minutes

Antibody incubation:

  • Block membrane with 5% non-fat milk in TBST for 1 hour at room temperature

  • Incubate with OsI_009113 Antibody at 1:500-1:1000 dilution in blocking buffer overnight at 4°C

  • Wash 3×10 minutes with TBST

  • Incubate with anti-rabbit HRP-conjugated secondary antibody (1:3000-1:5000) for 1 hour at room temperature

  • Wash 3×10 minutes with TBST

  • Develop using chemiluminescence detection

Critical considerations:

  • Include positive control (rice extract) and negative control (non-rice plant extract)

  • Optimize antibody concentration for each new lot

  • Always run a loading control (e.g., anti-actin)

  • Consider antigen retrieval if necessary for detecting native proteins

This protocol maximizes specific signal while minimizing background, ensuring reliable detection of OsI_009113 protein .

What controls should be included when using OsI_009113 Antibody in ELISA applications?

When designing ELISA experiments with OsI_009113 Antibody, a comprehensive set of controls is essential for obtaining reliable, interpretable results:

Essential controls for ELISA applications:

Control TypePurposeImplementation
Positive ControlConfirms antibody functionalityInclude purified OsI_009113 protein or known positive rice extract
Negative ControlDetects non-specific bindingInclude non-rice plant extract or OsI_009113-depleted sample
No Primary AntibodyMeasures secondary antibody backgroundOmit OsI_009113 Antibody, include only secondary antibody
No Secondary AntibodyMeasures endogenous enzyme activityInclude OsI_009113 Antibody but omit secondary antibody
Isotype ControlDetects non-specific bindingInclude rabbit IgG at same concentration
Standard CurveEnables quantificationSerial dilutions of recombinant OsI_009113 protein
Assay BlankMeasures reagent backgroundNo sample, no antibodies

Additionally, inclusion of a dilution series of the test sample helps establish the linear range of detection. For sandwich ELISA formats, epitope blocking controls should be considered to confirm specificity. Performing technical triplicates for each sample increases statistical confidence in the results .

How does sample preparation affect OsI_009113 detection efficiency in different applications?

Sample preparation significantly impacts the detection efficiency of OsI_009113 Antibody across different applications. This polyclonal antibody was developed against recombinant OsI_009113 protein, which may present epitopes differently than native protein in complex biological samples.

For protein extraction from rice tissues:

  • Mechanical disruption methods (grinding in liquid nitrogen) typically preserve protein structure better than chemical or detergent-based methods

  • Buffer composition affects epitope availability:

    • RIPA buffer (with 0.1% SDS): Suitable for Western blot applications

    • Non-denaturing buffers: Better for ELISA and immunoprecipitation

    • PBS-based extraction: Preserves native conformation for functional studies

Protein modifications affecting antibody binding:

  • Post-translational modifications (phosphorylation, glycosylation) may mask epitopes

  • Fixation procedures (for immunohistochemistry) can alter protein conformation

  • Reducing vs. non-reducing conditions significantly impact recognition of conformational epitopes

Optimization strategies:

  • Test multiple extraction protocols with gradient analysis of detection efficiency

  • Consider native vs. denaturing conditions based on experimental goals

  • Include protease and phosphatase inhibitors to preserve protein integrity

  • For fixed samples, optimize antigen retrieval methods (heat-induced vs. enzymatic)

A systematic comparison of different sample preparation methods is recommended when establishing protocols for new experimental systems to maximize detection sensitivity and specificity.

What are potential sources of data inconsistency when using OsI_009113 Antibody?

Researchers should be aware of several potential sources of data inconsistency when working with OsI_009113 Antibody:

Antibody-related factors:

  • Lot-to-lot variation: As a polyclonal antibody, different production lots may contain varying antibody populations with different epitope recognition profiles

  • Antibody degradation: Improper storage or multiple freeze-thaw cycles can reduce antibody activity

  • Concentration inconsistencies: Variations in working dilution preparation

Experimental design factors:

  • Inconsistent sample preparation methods between experiments

  • Variations in blocking reagents or incubation times

  • Temperature fluctuations during critical steps

Biological factors:

  • Developmental stage-dependent expression of OsI_009113 in rice

  • Stress-induced changes in protein expression or modification

  • Genetic variation between rice cultivars affecting epitope structure

Detection system variables:

  • Variations in secondary antibody quality or concentration

  • Inconsistent development times for Western blots

  • Equipment sensitivity differences between experiments

To mitigate these inconsistencies, researchers should:

  • Maintain detailed laboratory records of all protocols and reagents

  • Include internal standards and controls in every experiment

  • Validate new antibody lots against previous results

  • Standardize all experimental conditions and sample preparation methods

  • Consider biological replicates from independent rice samples

By systematically addressing these potential sources of variation, researchers can generate more consistent and reliable data using OsI_009113 Antibody.

How can cross-reactivity be assessed and managed when studying rice protein families with OsI_009113 Antibody?

Cross-reactivity assessment is particularly important for studies of rice proteins due to the presence of many homologous proteins and gene families. For OsI_009113 Antibody, managing potential cross-reactivity requires a strategic approach:

Systematic cross-reactivity assessment:

  • In silico analysis:

    • Perform sequence alignment of OsI_009113 with related rice proteins

    • Identify regions of high homology that might be recognized by the polyclonal antibody

    • Predict potential cross-reactive epitopes using epitope prediction algorithms

  • Experimental validation:

    • Express recombinant versions of closely related proteins

    • Perform Western blot analysis against these proteins to detect binding

    • Include gradient concentrations of primary antibody to assess binding affinity differences

  • Competitive binding assays:

    • Pre-incubate antibody with excess purified related proteins

    • Assess whether this pre-incubation reduces binding to OsI_009113

Management strategies for cross-reactivity:

  • Absorption techniques:

    • Pre-absorb antibody with recombinant related proteins to deplete cross-reactive antibodies

    • Create an "absorbed" version of the antibody for highly specific applications

  • Complementary approaches:

    • Confirm key findings with orthogonal techniques (mass spectrometry, RNA-seq)

    • Use genetic approaches (CRISPR, RNAi) to validate antibody specificity

  • Data interpretation:

    • Always acknowledge potential cross-reactivity in research publications

    • Provide quantitative assessments of cross-reactivity profiles

    • Consider development of more specific monoclonal antibodies for follow-up studies

By systematically assessing cross-reactivity and implementing appropriate management strategies, researchers can increase confidence in the specificity of their findings when using OsI_009113 Antibody.

What are common Western blot problems with OsI_009113 Antibody and how can they be resolved?

Western blot applications with OsI_009113 Antibody may encounter several common challenges. Here are solutions to typical problems:

High background:

  • Cause: Insufficient blocking or antibody concentration too high

  • Solution: Increase blocking time to 2 hours, optimize antibody dilution (try 1:1000-1:2000), and add 0.05% Tween-20 to washing buffer

Weak or no signal:

  • Cause: Insufficient antigen, antibody degradation, or inefficient transfer

  • Solution: Increase protein load (50-80 μg), verify antibody activity with dot blot, optimize transfer conditions, and consider longer primary antibody incubation (overnight at 4°C)

Multiple bands:

  • Cause: Protein degradation, cross-reactivity, or post-translational modifications

  • Solution: Add fresh protease inhibitors during extraction, perform pre-absorption with related proteins, analyze band patterns with mass spectrometry

Inconsistent results:

  • Cause: Variations in sample preparation or antibody handling

  • Solution: Standardize all protocols, prepare larger antibody working dilutions, include internal loading controls

Band size discrepancies:

  • Cause: Post-translational modifications or alternative splicing

  • Solution: Compare with recombinant protein standard, verify with mass spectrometry, check literature for known modifications

A systematic troubleshooting approach, testing one variable at a time and maintaining careful records of protocol modifications, will help identify and resolve issues with OsI_009113 Antibody applications.

How can researchers optimize immunoprecipitation protocols with OsI_009113 Antibody?

Immunoprecipitation (IP) with OsI_009113 Antibody requires careful optimization to achieve efficient target protein pulldown while minimizing non-specific binding. The following optimization strategy is recommended:

Buffer optimization:

  • Test multiple lysis buffers with varying detergent strengths:

    • Mild: 0.5% NP-40 or 1% Triton X-100 (preserves protein-protein interactions)

    • Moderate: RIPA buffer (better solubilization, may disrupt some interactions)

    • Stringent: Modified RIPA with 0.1-0.5% SDS (maximum solubilization)

Antibody coupling method comparison:

  • Direct approach: Pre-couple antibody to beads before sample addition

  • Indirect approach: Form antibody-antigen complexes in solution first, then capture with beads

  • Crosslinking approach: Covalently link antibody to beads to prevent antibody leaching

Antibody amount optimization:

  • Test gradient of antibody amounts (2-10 μg per reaction)

  • Determine minimum effective concentration for specific pulldown

Washing stringency assessment:

  • Evaluate multiple washing conditions from gentle to stringent

  • Monitor specificity vs. recovery trade-offs

Optimization verification:

  • Assess pulldown efficiency by immunoblotting input, unbound, and eluted fractions

  • Confirm specificity with mass spectrometry analysis of eluted fractions

Recommended immunoprecipitation protocol:

  • Prepare rice tissue lysate in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, with protease inhibitors

  • Clear lysate by centrifugation (14,000×g, 15 min, 4°C)

  • Pre-clear with Protein A/G beads (1 hour, 4°C)

  • Incubate cleared lysate with 5 μg OsI_009113 Antibody overnight at 4°C with rotation

  • Add Protein A beads and incubate 3 hours at 4°C

  • Wash 4× with lysis buffer and 1× with PBS

  • Elute with SDS sample buffer or low pH glycine buffer

This optimized protocol balances efficient target recovery with minimal background contamination.

How does OsI_009113 Antibody compare to other tools for studying rice protein expression?

When investigating rice protein expression, researchers have multiple methodological options. OsI_009113 Antibody offers distinct advantages and limitations compared to alternative approaches:

Comparison of methods for studying OsI_009113 expression:

MethodAdvantagesLimitationsComplementarity with Antibody
OsI_009113 Antibody- Direct protein detection
- Post-translational modification analysis
- Spatial localization capability
- Compatible with fixed tissues
- Potential cross-reactivity
- Limited quantitative precision
- Lot-to-lot variation
Primary detection method
RT-qPCR- High sensitivity
- Precise quantification
- High-throughput capability
- RNA ≠ protein levels
- No PTM information
- No spatial information
Validates expression at transcript level
RNA-seq- Genome-wide context
- Unbiased detection
- Isoform discrimination
- RNA ≠ protein levels
- Complex data analysis
- High cost
Provides transcriptional context
Mass Spectrometry- Direct protein detection
- High specificity
- PTM identification
- Complex sample preparation
- Expensive equipment
- Limited spatial information
Confirms antibody specificity
GFP Fusion Proteins- Live cell imaging
- Dynamic studies
- Single-cell resolution
- Potential functional interference
- Transgenic system required
- Overexpression artifacts
Validates subcellular localization

For comprehensive studies of OsI_009113, a multi-method approach is recommended. Initial antibody-based detection can establish baseline expression patterns, while orthogonal methods provide validation and additional layers of information .

What experimental design considerations are important when studying OsI_009113 across different rice varieties?

Studying OsI_009113 across different rice varieties requires careful experimental design to account for genetic diversity and environmental factors. Key considerations include:

Genetic considerations:

  • Sequence variation analysis:

    • Perform sequence alignment of OsI_009113 across target varieties

    • Identify polymorphisms that might affect antibody recognition

    • Consider custom antibodies for highly divergent varieties

  • Reference variety selection:

    • Include Oryza sativa subsp. indica (original immunogen source) as reference

    • Select varieties representing major rice groups (indica, japonica, aus)

Experimental design factors:

  • Controlled growth conditions:

    • Standardize all environmental parameters (light, temperature, nutrients)

    • Document developmental stages precisely for all varieties

    • Consider growth chamber experiments to minimize environmental variation

  • Sampling strategy:

    • Collect tissues at multiple developmental stages

    • Sample from identical anatomical positions

    • Implement technical and biological replicates (minimum n=3 for each variety)

  • Normalization approach:

    • Identify stable reference proteins across varieties for normalization

    • Consider ratio-based quantification relative to total protein

    • Include spike-in controls for absolute quantification

Analytical considerations:

  • Statistical analysis:

    • Apply appropriate statistical tests for cross-variety comparisons

    • Account for variance heterogeneity between varieties

    • Consider multivariate analysis for complex expression patterns

  • Data presentation:

    • Present results with normalized values and clear indication of variation

    • Include detailed methodological documentation of all variety-specific optimizations

    • Provide raw data access for reanalysis

This systematic approach ensures that observed differences in OsI_009113 expression or function reflect true biological variation rather than technical artifacts or experimental design flaws.

How can researchers integrate antibody-based detection of OsI_009113 with functional genomics approaches?

Integrating OsI_009113 Antibody-based detection with functional genomics creates powerful research opportunities. A comprehensive integration strategy includes:

Antibody-based detection with genetic manipulation:

  • CRISPR/Cas9 system:

    • Generate OsI_009113 knockout lines

    • Create epitope-tagged knockin lines

    • Develop point mutation lines targeting functional domains

    • Use antibody to verify knockout/knockin efficiency and specificity

  • RNAi approaches:

    • Design targeted knockdown constructs

    • Establish inducible silencing systems

    • Monitor protein depletion kinetics via antibody detection

    • Correlate phenotypes with protein reduction levels

Multi-omics integration strategies:

  • Proteomics integration:

    • Use antibody for co-immunoprecipitation followed by mass spectrometry

    • Identify OsI_009113 interaction partners

    • Map post-translational modifications

    • Compare interaction networks across conditions

  • Transcriptomics correlation:

    • Correlate protein levels (antibody detection) with transcript levels

    • Identify discrepancies suggesting post-transcriptional regulation

    • Link with gene co-expression networks

  • Metabolomics connections:

    • Compare metabolic profiles between wild-type and OsI_009113 mutants

    • Identify metabolite changes correlating with protein expression levels

    • Establish causal relationships through controlled expression systems

Phenotypic analysis framework:

  • Use antibody to quantify protein levels across developmental stages

  • Correlate protein expression with phenotypic traits

  • Develop predictive models connecting protein abundance to plant performance

This integrated approach leverages the specificity of antibody-based detection while providing functional context through complementary genomic, transcriptomic, and metabolomic data, ultimately yielding a comprehensive understanding of OsI_009113 function in rice biology.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.